BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang YQ, Pan D, Yao ZY, Li YQ, Qu PF, Wang RB, Gu QH, Jiang J, Han ZX, Liu HN. Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy. World J Gastroenterol 2024; 30(37): 4132-4148 [PMID: 39474397 DOI: 10.3748/wjg.v30.i37.4132]
URL: https://www.wjgnet.com/2218-4333/full/v30/i37/4132.htm
Number Citing Articles
1
Camrelizumab/lenvatinibReactions Weekly 2024; 2035(1): 126 doi: 10.1007/s40278-024-70876-8
2
Yun Feng, Bingran Yu, Anxiao Liu, Chongpeng Cai, Changming Zhou, Tong Tong, Lu Wang, Qi Pan. Prognostic impact of body composition in hepatocellular carcinoma patients undergoing interventional and systemic therapyFrontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1586202